GSK (GSK) Insider Trading & Ownership GBX 1,308.50 -13.50 (-1.02%) (As of 12/20/2024 12:31 PM ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsDividendHeadlinesInsider TradesSustainability GSK (LON:GSK) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage1.61%Number OfInsiders Buying(Last 12 Months)6Amount OfInsider Buying(Last 12 Months)£430,193.90Number OfInsiders Selling(Last 12 Months)1Amount OfInsider Selling(Last 12 Months)£2.32 M Get GSK Insider Trade Alerts Want to know when executives and insiders are buying or selling GSK stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address GSK Insider Buying and Selling by Quarter Ad DTIWhy I'm telling friends to avoid gold stocksBack in November, gold made a tiny move of 1.6%. But according to my backtesting by using a special type of gold trade, I would have seen a 141% gain in just a week. It happened again in March. Gold nudged up 1.2%. This time? A 104% overnight gain. And in June? A 1% gold move turned into a 74% gain in two weeks. Granted, there would have been smaller wins and those that did not work out, but you see, there's a reason I'm telling all my friends to hold off from buying gold or regular gold stocks right now. There's a more lucrative way to play the gold market as we enter a new breakout period. It's all about catching what I call "Acceleration Cycles."And if you’d like to get your hands on this, here you go, the complete breakdown. GSK Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails11/11/2024Julie BrownInsiderBuy8GBX 1,399£111.9210/30/2024Jonathan SymondsInsiderBuy7,150GBX 1,394£99,6719/23/2024Elizabeth (Liz) McKee AndersonInsiderBuy446GBX 2,051£9,147.468/9/2024Julie BrownInsiderBuy8GBX 1,505£120.406/20/2024Wendy BeckerInsiderBuy446GBX 1,614£7,198.446/11/2024Julie BrownInsiderBuy8GBX 1,623£129.84 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 3/20/2024Urs RohnerInsiderBuy434GBX 1,662£7,213.082/16/2024Emma WalmsleyInsiderSell139,792GBX 1,658£2,317,751.362/9/2024Emma WalmsleyInsiderBuy8GBX 1,662£132.962/1/2024Julie BrownInsiderBuy19,360GBX 1,583£306,468.80 (Data available from 1/1/2013 forward) GSK Insider Trading Activity - Frequently Asked Questions Who is on GSK's Insider Roster? The list of insiders at GSK includes Charles Bancroft, Elizabeth (Liz) McKee Anderson, Emma Walmsley, Hal Barron, Iain Mackay, Jonathan Symonds, Julie Brown, Manvinder Singh Banga, Urs Rohner, and Wendy Becker. Learn more on insiders at GSK. What percentage of GSK stock is owned by insiders? 1.61% of GSK stock is owned by insiders. Learn more on GSK's insider holdings. Which GSK insiders have been buying company stock? The following insiders have purchased GSK shares in the last 24 months: Elizabeth (Liz) McKee Anderson (£9,147.46), Emma Walmsley (£878.14), Hal Barron (£8,328.57), Iain Mackay (£2,986), Jonathan Symonds (£215,450), Julie Brown (£306,830.96), Urs Rohner (£25,739.02), and Wendy Becker (£7,198.44). How much insider buying is happening at GSK? Insiders have purchased a total of 37,716 GSK shares in the last 24 months for a total of £576,558.59 bought. Which GSK insiders have been selling company stock? The following insiders have sold GSK shares in the last 24 months: Emma Walmsley (£2,742,676.48), and Hal Barron (£673,220.52). How much insider selling is happening at GSK? Insiders have sold a total of 187,814 GSK shares in the last 24 months for a total of £3,415,897 sold. GSK Key ExecutivesMs. Emma Natasha Walmsley (Age 55)CEO & Director Compensation: $5.39MMs. Julie Belita Brown (Age 62)CFO & Executive Director Compensation: $5.14MMs. Shobie Ramakrishnan (Age 53)Chief Digital & Technology Officer Mr. Tony WoodChief Scientific Officer and Head of R&DMs. Sarah Elton-FarrHead of Investor RelationsMr. James FordSenior VP & Group General Counsel of Legal & ComplianceMs. Sally JacksonSenior Vice President of Global Communications & CEO OfficeMr. David Simon Redfern BSc (Hons) (Age 58)CA, President of Corporate Development Ms. Diana ConradChief People OfficerMr. Philip C. ThomsonPresident of Global Affairs More Insider Trading Tools from MarketBeat Related Companies AZN Insider Trading ITH Insider Trading GRI Insider Trading INDV Insider Trading BMY Insider Trading IGC Insider Trading ARTL Insider Trading PHAR Insider Trading MRK Insider Trading REVB Insider Trading Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles AppLovin Insiders Sell Shares: Stock Price Indicated Higher Are 2024’s Top Insider Buys a Good Bet for 2025? Bargains Galore? 3 Stocks With Insider Buying in the MillionsInsiders Keep Buying These Stocks: 2 to Buy, 1 to AvoidZeta Global Holdings Insiders Buy Stock After Short-Report This page (LON:GSK) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GSK plc Please log in to your account or sign up in order to add this asset to your watchlist. Share GSK With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GSK Stock Alerts